Duchenne muscular dystrophy diagnosis using fibroblast‐derived myotube cells

Pediatrics InternationalVolume 64, Issue 1 e15151 Clinical Notes Duchenne muscular dystrophy diagnosis using fibroblast-derived myotube cells Yuki Okada, Yuki Okada Department of Pediatrics, National Hospital Organization Nagara Medical Center, Gifu, Japan Department of Pediatric Medical Care, Gifu Prefectural General Medical Center, Gifu, JapanSearch for more papers by this authorMichinori Funato, Corresponding Author Michinori Funato mfunato@mac.com orcid.org/0000-0001-8836-8333 Department of Pediatrics, National Hospital Organization Nagara Medical Center, Gifu, Japan Correspondence: Michinori Funato, MD PhD, Department of Pediatrics, National Hospital Organization Nagara Medical Center, 1300-7 Nagara, Gifu 502-8558, Japan. Email: mfunato@mac.comSearch for more papers by this authorShin'ichi Takeda, Shin'ichi Takeda Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, JapanSearch for more papers by this authorHideo Kaneko, Hideo Kaneko orcid.org/0000-0002-9269-8017 Department of Pediatrics, National Hospital Organization Nagara Medical Center, Gifu, Japan Department of Pediatric Medical Care, Gifu Prefectural General Medical Center, Gifu, JapanSearch for more papers by this author Yuki Okada, Yuki Okada Department of Pediatrics, National Hospital Organization Nagara Medical Center, Gifu, Japan Department of Pediatric Medical Care, Gifu Prefectural General Medical Center, Gifu, JapanSearch for more papers by this authorMichinori Funato, Corresponding Author Michinori Funato mfunato@mac.com orcid.org/0000-0001-8836-8333 Department of Pediatrics, National Hospital Organization Nagara Medical Center, Gifu, Japan Correspondence: Michinori Funato, MD PhD, Department of Pediatrics, National Hospital Organization Nagara Medical Center, 1300-7 Nagara, Gifu 502-8558, Japan. Email: mfunato@mac.comSearch for more papers by this authorShin'ichi Takeda, Shin'ichi Takeda Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, JapanSearch for more papers by this authorHideo Kaneko, Hideo Kaneko orcid.org/0000-0002-9269-8017 Department of Pediatrics, National Hospital Organization Nagara Medical Center, Gifu, Japan Department of Pediatric Medical Care, Gifu Prefectural General Medical Center, Gifu, JapanSearch for more papers by this author First published: 26 May 2022 https://doi.org/10.1111/ped.15151Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume64, Issue1January/December 2022e15151 RelatedInformation